Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Intel’s Critical Juncture: Can the Chipmaker Sustain Its Resurgence?

Robert Sasse by Robert Sasse
October 21, 2025
in Analysis, Earnings, Semiconductors, Tech & Software, Turnaround
0
Intel Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Intel finds itself at a pivotal crossroads as the semiconductor industry intensifies its focus on artificial intelligence processors. While many investors had written off the chipmaker amid fierce competition, recent developments have injected fresh momentum into its stock performance. The timing of Morgan Stanley’s substantial price target revision—just seventy-two hours before Intel’s eagerly anticipated quarterly results—raises compelling questions about the company’s trajectory.

Strategic Alliances Fueling Optimism

Intel’s recent strategic maneuvers have significantly bolstered its market position. The technology giant unveiled its Panther Lake Architecture on October 9, representing the inaugural AI-PC chip built on the advanced 18A process node. This development marks a crucial advancement in Intel’s campaign to reclaim market share within the artificial intelligence sector.

Perhaps even more consequential is the partnership established with NVIDIA on September 18. Under this arrangement, Intel will manufacture custom processors incorporating NVIDIA’s technology, supported by a substantial $5 billion investment commitment. This collaboration not only provides essential capital infusion but also enhances Intel’s credibility in pursuing its foundry ambitions, signaling to the market that major industry players are willing to trust Intel’s manufacturing capabilities.

Morgan Stanley’s Conviction Shift

Market analysts at Morgan Stanley made waves on October 20 by dramatically elevating their price objective for Intel shares from $23 to $36—representing a striking 56.52 percent increase. Although research analyst Joseph Moore maintained his neutral rating on the stock, the substantial upward revision clearly indicates growing confidence in Intel’s turnaround narrative.

Should investors sell immediately? Or is it worth buying Intel?

The proximity of this adjustment to Intel’s quarterly earnings release—scheduled for just three days later—suggests Morgan Stanley possesses compelling rationale for reassessing the company’s valuation prospects.

Earnings Expectations Signal Potential Inflection

Technical indicators preceding Intel’s October 23 quarterly report reveal unusually bullish sentiment. With an Earnings ESP reading of +116.67 percent and a Zacks Rating of #3, historical patterns suggest nearly 70 percent probability of positive earnings surprises.

Notably, market experts project break-even earnings per share for the third quarter of 2025—which would constitute a 100 percent improvement compared to the loss recorded during the same period last year. With anticipated revenue reaching $13.11 billion, Intel appears positioned to initiate a meaningful operational turnaround despite persistent challenges in the semiconductor landscape.

The quarterly results, scheduled for release Thursday at 11:00 PM German time, will ultimately determine whether Intel has established foundation for sustainable recovery or whether recent stock appreciation represents merely temporary enthusiasm.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from March 25 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Intel: Buy or sell? Read more here...

Tags: Intel
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Glencore Stock
Analysis

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

March 25, 2026
Take-Two Stock
Earnings

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
Next Post
MicroStrategy Stock

MicroStrategy Doubles Down on Bitcoin Strategy Amid Market Volatility

Ryohin Keikaku Stock

Muji Parent Company Faces Market Turbulence Following Cyberattack on Logistics Partner

AppFolio Stock

AppFolio's AI Ambition Faces Valuation Reality Check

Recommended

Finance_Cash

Important Information for Investors Dividend Distribution and Key Dates for First Commonwealth NYSE FCF Stock

2 years ago
iShares MSCI World ETF Stock

The Hidden Concentration Risk in Your Global ETF Portfolio

5 months ago
Assembly Biosciences Stock

Assembly Biosciences Shares Extend Losses Amid Heavy Selling Pressure

6 months ago

Raymond James Financial Services Advisors Inc. Decreases Holdings in Snap-on Incorporated: Examining Investment Strategy Shift and Analyst Perspectives

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Trending

Glencore Stock
Analysis

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

by Jackson Burston
March 25, 2026
0

While the broader copper market faces significant headwinds, shares in the diversified mining and trading giant Glencore...

Energiekontor Stock

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026
Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Glencore Shares Demonstrate Resilience Amid Copper Market Weakness
  • Energiekontor Stock Gains Momentum from Policy Shifts
  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com